Novo Nordisk: Oral Weight-Loss To The Rescue [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
NVO's oral Wegovy pill demonstrated superior weight-loss efficacy versus Eli Lilly's orforglipron, with 16.6% mean loss and 34.4% of patients exceeding 20% weight loss. The stock trades at just 15x EPS, near multi-year lows, despite a massive market opportunity projected to quintuple by 2035. The stock is cheap trading at only $52 after falling from highs around $150. geckophotos/iStock via Getty Images Novo Nordisk A/S NVO ) got a big boost as the weight-loss drugmaker became the first company to get FDA approval for an oral GLP-1 drug. The big question for 2026 is whether Novo Nordisk can grab a first-mover advantage More on my IG service If you'd like to learn more about how to best position yourself in under valued stocks mispriced by the market to end December, consider joining Out Fox The Street The service offers a model portfolio, daily updates, trade alerts and real-time chat. Sign up now for a risk-free 2-week trial to started finding the best stocks with pote
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk (NVO) Gets 9% Boost from Wegovy Pill OK [Yahoo! Finance]Yahoo! Finance
- The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA. [Yahoo! Finance]Yahoo! Finance
- Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (Rating Upgrade) [Seeking Alpha]Seeking Alpha
- Novo Nordisk just pulled off something nobody saw coming [Yahoo! Finance]Yahoo! Finance
- 3 Drug Stocks to Buy at a Discount [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website